Royalty says it will pay $12.50 in cash for each share of Elan.
Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders GENEVA , May 21, 2013 /PRNewswire...
Peregrine rises on agreement for late-stage study WASHINGTON (AP) — Shares of Peregrine Pharmaceuticals Inc. surged Monday after the company said it...
An interim analysis showed the drug wasn't helping patients live longer
Rise and shine, everyone. Another busy day is on the way, and we are no exception. We have an interesting meeting planned and, of course, various...
Welcome to the working week. Hope your weekend was pleasant. We accomplished sundry errands and spent time with the Pharmalittles, among other things. Now, though, the usual routine beckons. And so here are a few items to get you started while we research still more. Have a good day, everyone...
Merck Shingles Vaccines Remains In Short Supply (The Wichita Eagle)
King Extends Tender Offer For Alpharma (press release)
More Consumers Getting Health Info On The Internet (PharmaTimes)
